Bli medlem
Bli medlem

Du är här


RaySearch Laboratories: The Chairman of the Board of RaySearch Laboratories AB (publ) resigns

RaySearch's Chairman, Erik Hedlund, resigns from the Board with
immediate effect following disagreement with the CEO. The remaining
members of the Board express their full confidence in their CEO. The
Board has appointed board member Carl Filip Bergendal as new Chairman
until the Annual General Meeting, which will be held on 24 May, 2017.

"RaySearch's business operations continue to develop well and
according to plan and won't be affected negatively by this", says
Johan Löf, CEO.

"The Board would like to thank Erik for his contribution to the
company's development during his time as Chairman of the Board", says
Carl Filip Bergendal, Chairman of the Board.

Erik Hedlund has been a member of RaySearch's Board of Directors since
2000. In conjunction with his resignation, Erik Hedlund has requested
that his RaySearch shares of Series A be converted into shares of
Series B.

About RaySearch
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch develops and markets the RayStation treatment planning
system to clinics all over the world and distributes the products
through licensing agreements with leading medical technology
companies. The company is also developing the next-generation
oncology information system, RayCare, which comprises a new product
area for RaySearch, and will be launched in 2017. RaySearch's
software is currently used by over 2,600 clinics in more than 65
countries. The company was founded in 2000 as a spin-off from the
Karolinska Institute in Stockholm and the share has been listed on
Nasdaq Stockholm since November 2003.

For more information about RaySearch, please visit

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.